Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.99B |
| 2 |
Apple
AAPL
|
+$2.23B |
| 3 |
NVIDIA
NVDA
|
+$1.92B |
| 4 |
Amazon
AMZN
|
+$1.75B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altair Engineering Inc
ALTR
|
+$152M |
| 2 |
Merck
MRK
|
+$142M |
| 3 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
+$141M |
| 4 |
ALTM
Arcadium Lithium plc
ALTM
|
+$132M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.36% |
| 2 | Financials | 14.54% |
| 3 | Healthcare | 11.04% |
| 4 | Consumer Discretionary | 10.44% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSBX
4176
DELISTED
Turnstone Biologics
TSBX
| $56.1K | ﹤0.01% |
136,780
-1,879
| -1% | -$800 |
|
|
DHAI
4177
DELISTED
DIH Holdings US
DHAI
| $55.4K | ﹤0.01% |
9,574
+5
| +0.1% | +$93 |
|
4178
Presidio Property Trust
SQFT
$2.89M
| $55.3K | ﹤0.01% |
9,621
-1,660
| -15% | -$10.9K |
|
4179
Kiora Pharmaceuticals
KPRX
$11.5M
| $55.2K | ﹤0.01% |
18,347
+2,390
| +15% | +$8.3K |
|
4180
Investcorp Credit Management BDC
ICMB
$11.8M
| $54.7K | ﹤0.01% |
16,938
| – | – |
|
4181
Arbe Robotics
ARBE
$86.5M
| $54.6K | ﹤0.01% |
53,025
| – | – |
|
4182
Oramed Pharmaceuticals
ORMP
$180M
| $54.5K | ﹤0.01% |
25,455
| – | – |
|
4183
Socket Mobile
SCKT
$3.39M
| $54.5K | ﹤0.01% |
48,204
+9,171
| +23% | +$12K |
|
4184
AgEagle Aerial Systems
UAVS
$42.1M
| $54.4K | ﹤0.01% |
+42,160
| New | +$83.8K |
|
4185
Plus Therapeutics
PSTV
$26.6M
| $54.2K | ﹤0.01% |
2,282
-44
| -2% | -$1.23K |
|
4186
Phio Pharmaceuticals
PHIO
$12M
| $54.1K | ﹤0.01% |
+41,586
| New | +$76.8K |
|
|
SNT
4187
Senstar Technologies
SNT
$43.6M
| $53.8K | ﹤0.01% |
15,517
| – | – |
|
4188
Neuraxis
NRXS
$82.2M
| $53.7K | ﹤0.01% |
24,970
+2,266
| +10% | +$5.46K |
|
|
TULP
4189
Bloomia Holdings
TULP
$16M
| $53.1K | ﹤0.01% |
14,197
-2,297
| -14% | -$9.5K |
|
4190
Arts-Way Manufacturing Co
ARTW
$11.2M
| $52.9K | ﹤0.01% |
33,288
+6,194
| +23% | +$10.7K |
|
4191
Eterna Therapeutics
ERNA
$4.02M
| $52.2K | ﹤0.01% |
782
+96
| +14% | +$11.8K |
|
4192
Silo Pharma
SILO
$4.88M
| $52K | ﹤0.01% |
2,966
+636
| +27% | +$14.2K |
|
4193
GT Biopharma
GTBP
$11.1M
| $51.7K | ﹤0.01% |
23,086
+8,187
| +55% | +$19.3K |
|
|
NB
4194
NioCorp Developments
NB
$649M
| $51.2K | ﹤0.01% |
26,012
| – | – |
|
4195
Banzai International
BNZI
$6.43M
| $51.1K | ﹤0.01% |
+228
| New | +$64.2K |
|
|
CRDL
4196
Cardiol Therapeutics
CRDL
$151M
| $50.9K | ﹤0.01% |
52,435
| – | – |
|
|
IHT
4197
InnSuites Hospitality Trust
IHT
$15.3M
| $50.7K | ﹤0.01% |
22,444
-2,898
| -11% | -$7.33K |
|
|
HERE
4198
Here Group Ltd
HERE
$104M
| $50.1K | ﹤0.01% |
12,461
| – | – |
|
|
XMAX
4199
XMAX Inc
XMAX
$558M
| $50.1K | ﹤0.01% |
73,742
+15,417
| +26% | +$9.14K |
|
4200
DNA X Inc
SONM
$5.73M
| $49.5K | ﹤0.01% |
1,285
+128
| +11% | +$6.11K |
|
Similar funds
Geode Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Geode Capital Management held 4,591 positions worth $1.27T, down 1.4% from $1.29T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Geode Capital Management deployed $47.9B of net new capital in Q1 2025, opening 121 new positions and adding to 3,781 existing holdings. Its largest new stake was Sandisk: 1,936,245 shares worth $92.2M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Merck, an estimated $142M trimmed.
- Geode Capital Management's largest Q1 2025 buy was Sandisk: 1,936,245 shares worth $92.2M.
- Geode Capital Management added most to Microsoft in Q1 2025, an estimated $2.99B increase.
- Geode Capital Management's biggest Q1 2025 reduction was Merck, cutting an estimated $142M.
- Geode Capital Management fully exited Altair Engineering Inc in Q1 2025, selling an estimated $152M.
- Geode Capital Management's ten largest holdings make up 29% of its $1.27T portfolio in Q1 2025.
- Geode Capital Management opened 121 new positions and closed 115 in Q1 2025.
- Geode Capital Management's portfolio value fell 1.4% quarter-over-quarter to $1.27T.
Based on Geode Capital Management's 13F filing for Q1 2025, filed 13 May 2025.